Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Bonardi

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
ACS Medicinal Chemistry Letters|June 14, 2023
Discovery of Novel Hydroxyimine-Tethered Benzenesulfonamides as Potential Human Carbonic Anhydrase IX/XII InhibitorsMudasir Nabi Peerzada, Daniela Vullo, Niccolò Paoletti, et al.
International Journal of Molecular Sciences|November 26, 2022
Probing the Efficiency of 13-Pyridylalkyl Berberine Derivatives to Human Telomeric G-Quadruplexes Binding: Spectroscopic, Solid State and In Silico AnalysisCarla Bazzicalupi, Alessandro Bonardi, Tarita Biver, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Investigation on <i>N</i>-Aryl-2-(4-sulfamoylphenyl)hydrazine-1-carbothioamide as Human Carbonic Anhydrases InhibitorsMorteza Abdoli, Andrea Angeli, Alessandro Bonardi, et al.
Molecules (Basel, Switzerland)|May 27, 2023
Inhibition Studies on Human and Mycobacterial Carbonic Anhydrases with <i>N</i>-((4-Sulfamoylphenyl)carbamothioyl) AmidesMorteza Abdoli, Alessandro Bonardi, Niccolò Paoletti, et al.
Journal of Medicinal Chemistry|September 19, 2022
Development of Hydrogen Sulfide-Releasing Carbonic Anhydrases IX- and XII-Selective Inhibitors with Enhanced Antihyperalgesic Action in a Rat Model of ArthritisAlessandro Bonardi, Laura Micheli, Lorenzo Di Cesare Mannelli, et al.
Archiv Der Pharmazie|December 17, 2024
Exploring aliphatic sulfonamides as multiclass inhibitors of the carbonic anhydrases from the pathogen bacterium Vibrio choleraeNiccolò Paoletti, Simone Giovannuzzi, Alessandro Bonardi, et al.
International Journal of Molecular Sciences|September 28, 2024
Hydrogen Sulfide-Releasing Carbonic Anhydrase Inhibitors Effectively Suppress Cancer Cell GrowthAlessandro Bonardi, Alessio Nocentini, Viviana de Luca, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 17, 2023
Sulphonamide inhibition studies of the β-carbonic anhydrase GsaCAβ present in the salmon platyhelminth parasite <i>Gyrodactylus salaris</i>Ashok Aspatwar, Alessandro Bonardi, Heidi Aisala, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 20, 2023
Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitorsNora Astrain-Redin, Niccolò Paoletti, Daniel Plano, et al.
Archiv Der Pharmazie|October 1, 2021
Novel benzenesulfonamide-bearing pyrazoles and 1,2,4-thiadiazoles as selective carbonic anhydrase inhibitorsRajiv Kumar, Amit Kumar, Sita Ram, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
ACS Medicinal Chemistry Letters|June 14, 2023
Discovery of Novel Hydroxyimine-Tethered Benzenesulfonamides as Potential Human Carbonic Anhydrase IX/XII InhibitorsMudasir Nabi Peerzada, Daniela Vullo, Niccolò Paoletti, et al.
International Journal of Molecular Sciences|November 26, 2022
Probing the Efficiency of 13-Pyridylalkyl Berberine Derivatives to Human Telomeric G-Quadruplexes Binding: Spectroscopic, Solid State and In Silico AnalysisCarla Bazzicalupi, Alessandro Bonardi, Tarita Biver, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Investigation on <i>N</i>-Aryl-2-(4-sulfamoylphenyl)hydrazine-1-carbothioamide as Human Carbonic Anhydrases InhibitorsMorteza Abdoli, Andrea Angeli, Alessandro Bonardi, et al.
Molecules (Basel, Switzerland)|May 27, 2023
Inhibition Studies on Human and Mycobacterial Carbonic Anhydrases with <i>N</i>-((4-Sulfamoylphenyl)carbamothioyl) AmidesMorteza Abdoli, Alessandro Bonardi, Niccolò Paoletti, et al.
Journal of Medicinal Chemistry|September 19, 2022
Development of Hydrogen Sulfide-Releasing Carbonic Anhydrases IX- and XII-Selective Inhibitors with Enhanced Antihyperalgesic Action in a Rat Model of ArthritisAlessandro Bonardi, Laura Micheli, Lorenzo Di Cesare Mannelli, et al.
Archiv Der Pharmazie|December 17, 2024
Exploring aliphatic sulfonamides as multiclass inhibitors of the carbonic anhydrases from the pathogen bacterium Vibrio choleraeNiccolò Paoletti, Simone Giovannuzzi, Alessandro Bonardi, et al.
International Journal of Molecular Sciences|September 28, 2024
Hydrogen Sulfide-Releasing Carbonic Anhydrase Inhibitors Effectively Suppress Cancer Cell GrowthAlessandro Bonardi, Alessio Nocentini, Viviana de Luca, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 17, 2023
Sulphonamide inhibition studies of the β-carbonic anhydrase GsaCAβ present in the salmon platyhelminth parasite <i>Gyrodactylus salaris</i>Ashok Aspatwar, Alessandro Bonardi, Heidi Aisala, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 20, 2023
Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitorsNora Astrain-Redin, Niccolò Paoletti, Daniel Plano, et al.
Archiv Der Pharmazie|October 1, 2021
Novel benzenesulfonamide-bearing pyrazoles and 1,2,4-thiadiazoles as selective carbonic anhydrase inhibitorsRajiv Kumar, Amit Kumar, Sita Ram, et al.
Pageof 11